Insulin Resistance and Metabolic Syndrome are more prominent in Indian/Asian Population due to GLP-1 and UCP-1 downregulation leading to lower Skeletal Mass and high Visceral Adiposity.
Disclaimer: Above data / claim is based on the clinical evidence obtained from GLP-1 RA, UCP-1 and individual API molecules, Individual Results may vary*